ロード中...
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
Biologics have changed expectation and outcomes for rheumatoid arthritis (RA). However, the optimal duration and sequence of therapy for this disease has yet to be determined. Also, a significant number of patients do not satisfactorily respond to currently available therapies. The Janus kinase (JAK...
保存先:
| 出版年: | Ther Adv Musculoskelet Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315227/ https://ncbi.nlm.nih.gov/pubmed/28255337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16687481 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|